US digital pathology firm Corista has announced a strategic partnership with AGFA HealthCare, a renowned name in diagnostic imaging and healthcare IT solutions. This alliance represents an important advancement in healthcare technology, integrating Corista's DP3 technology with AGFA HealthCare’s Enterprise Imaging for Pathology platform.
Corista unveils AGFA HealthCare partnershiThe integration of Corista’s DP3 technology into AGFA HealthCare’s Enterprise Imaging Platform is a notable step in advancing integrated healthcare. This collaboration aims to enable healthcare organisations to deliver more efficient and precise care across critical medical specialties.
Elizabeth Wingard, CEO and Co-founder of Corista, comments on the partnership: "Our collaboration with AGFA HealthCare is a testament to our shared commitment to healthcare excellence. Corista’s experience with top academic institutions complements AGFA’s vision for enterprise medical imaging, creating a seamless care continuum that extends the benefits of AI and digital integration directly to patient care."
Dr Anjum Ahmed, Chief Medical Officer at AGFA HealthCare, adds: "By integrating Corista's DP3 technology into our Enterprise Imaging Platform, we're empowering pathologists with advanced tools to enhance diagnostic confidence and efficiency. Our goal is to streamline the complex pathology workflow, so that patients receive the benefit of rapid, precise, and integrated healthcare delivery."
Corista has been at the forefront of developing digital pathology solutions, and its collaboration with AGFA HealthCare marks a crucial step in broadening the scope of integrated healthcare. This partnership facilitates enhanced collaboration among different medical specialties, leading to more streamlined and precise patient care.
Corista DP3 is certified for diagnostic use under CE-IVDR. AGFA HealthCare’s Enterprise Imaging for Pathology is available in the UK and Europe only.